image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 27.21
1.53 %
$ 1.58 B
Market Cap
-18.64
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one PHR stock under the worst case scenario is HIDDEN Compared to the current market price of 27.2 USD, Phreesia, Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one PHR stock under the base case scenario is HIDDEN Compared to the current market price of 27.2 USD, Phreesia, Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one PHR stock under the best case scenario is HIDDEN Compared to the current market price of 27.2 USD, Phreesia, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
356 M REVENUE
26.84%
-132 M OPERATING INCOME
25.36%
-137 M NET INCOME
22.29%
-32.4 M OPERATING CASH FLOW
64.07%
-39.7 M INVESTING CASH FLOW
-51.39%
-17.1 M FINANCING CASH FLOW
16.13%
107 M REVENUE
4.59%
-13.8 M OPERATING INCOME
19.62%
-14.4 M NET INCOME
20.04%
5.78 M OPERATING CASH FLOW
-47.70%
-4.18 M INVESTING CASH FLOW
43.51%
-1.65 M FINANCING CASH FLOW
-19.55%
Balance Sheet Phreesia, Inc.
image
Current Assets 196 M
Cash & Short-Term Investments 87.5 M
Receivables 64.9 M
Other Current Assets 43.3 M
Non-Current Assets 175 M
Long-Term Investments 0
PP&E 17.2 M
Other Non-Current Assets 157 M
Current Liabilities 110 M
Accounts Payable 8.48 M
Short-Term Debt 6.45 M
Other Current Liabilities 95.2 M
Non-Current Liabilities 8.76 M
Long-Term Debt 5.53 M
Other Non-Current Liabilities 3.22 M
EFFICIENCY
Earnings Waterfall Phreesia, Inc.
image
Revenue 356 M
Cost Of Revenue 124 M
Gross Profit 232 M
Operating Expenses 370 M
Operating Income -132 M
Other Expenses 5.11 M
Net Income -137 M
RATIOS
65.19% GROSS MARGIN
65.19%
-36.98% OPERATING MARGIN
-36.98%
-38.42% NET MARGIN
-38.42%
-54.44% ROE
-54.44%
-36.96% ROA
-36.96%
-52.35% ROIC
-52.35%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Phreesia, Inc.
image
Net Income -137 M
Depreciation & Amortization 29.5 M
Capital Expenditures -25.1 M
Stock-Based Compensation 71.6 M
Change in Working Capital -1.64 M
Others 16.4 M
Free Cash Flow -57.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Phreesia, Inc.
image
Wall Street analysts predict an average 1-year price target for PHR of $30.9 , with forecasts ranging from a low of $23 to a high of $35 .
PHR Lowest Price Target Wall Street Target
23 USD -15.47%
PHR Average Price Target Wall Street Target
30.9 USD 13.59%
PHR Highest Price Target Wall Street Target
35 USD 28.63%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Phreesia, Inc.
image
Sold
0-3 MONTHS
2.84 M USD 5
3-6 MONTHS
1.33 M USD 9
6-9 MONTHS
237 K USD 8
9-12 MONTHS
6.91 M USD 8
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Dec 18, 2024
Sell 87 K USD
Hoffman Allison C
General Counsel & Secretary
- 3495
24.88 USD
1 month ago
Dec 18, 2024
Sell 609 USD
Linetsky David
SVP, Life Sciences
- 24
25.376 USD
1 month ago
Dec 16, 2024
Sell 871 USD
Linetsky David
SVP, Life Sciences
- 35
24.8825 USD
1 month ago
Dec 17, 2024
Sell 1.48 K USD
Linetsky David
SVP, Life Sciences
- 59
25.0385 USD
1 month ago
Dec 17, 2024
Sell 51.5 USD
Linetsky David
SVP, Life Sciences
- 2
25.7663 USD
1 month ago
Dec 13, 2024
Sell 515 K USD
Weintraub Michael
Director
- 20565
25.0444 USD
1 month ago
Dec 16, 2024
Sell 21.8 K USD
Weintraub Michael
Director
- 861
25.2638 USD
1 month ago
Dec 11, 2024
Sell 466 K USD
Weintraub Michael
Director
- 18574
25.0991 USD
1 month ago
Dec 11, 2024
Sell 295 K USD
Linetsky David
SVP, Life Sciences
- 11853
24.851 USD
1 month ago
Dec 10, 2024
Sell 602 K USD
Roberts Evan
Chief Operating Officer
- 25000
24.0864 USD
1 month ago
Dec 03, 2024
Sell 533 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 25447
20.9282 USD
1 month ago
Dec 02, 2024
Sell 318 K USD
Weintraub Michael
Director
- 15152
21.0116 USD
3 months ago
Oct 18, 2024
Sell 22.5 K USD
Linetsky David
SVP, Life Sciences
- 1100
20.49 USD
3 months ago
Oct 15, 2024
Sell 18.2 K USD
Gandhi Balaji
Chief Financial Officer
- 864
21.0251 USD
3 months ago
Oct 15, 2024
Sell 25.5 K USD
Hoffman Allison C
General Counsel & Secretary
- 1212
21.0251 USD
3 months ago
Oct 15, 2024
Sell 64.9 K USD
Indig Chaim
Chief Executive Officer
- 3089
21.0251 USD
3 months ago
Oct 15, 2024
Sell 42.3 K USD
Linetsky David
SVP, Life Sciences
- 2011
21.0251 USD
3 months ago
Oct 15, 2024
Sell 38.7 K USD
Roberts Evan
Chief Operating Officer
- 1843
21.0251 USD
3 months ago
Oct 15, 2024
Sell 13.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 624
21.0251 USD
3 months ago
Oct 15, 2024
Sell 52 K USD
Hui Yvonne
Principal Accounting Officer
- 2485
20.91 USD
3 months ago
Oct 15, 2024
Sell 6.43 K USD
Hui Yvonne
Principal Accounting Officer
- 306
21.0251 USD
3 months ago
Oct 16, 2024
Sell 9.02 K USD
Hui Yvonne
Principal Accounting Officer
- 423
21.33 USD
4 months ago
Sep 19, 2024
Sell 577 USD
Linetsky David
SVP, Life Sciences
- 24
24.0433 USD
4 months ago
Sep 17, 2024
Sell 892 USD
Linetsky David
SVP, Life Sciences
- 36
24.7651 USD
4 months ago
Sep 18, 2024
Sell 1.47 K USD
Linetsky David
SVP, Life Sciences
- 61
24.0866 USD
4 months ago
Sep 12, 2024
Sell 32.2 K USD
Egbuonu-Davis Lisa
Director
- 1400
23.028 USD
4 months ago
Sep 10, 2024
Sell 81.4 K USD
Gandhi Balaji
Chief Financial Officer
- 3502
23.2502 USD
4 months ago
Sep 10, 2024
Sell 17.3 K USD
Hui Yvonne
Principal Accounting Officer
- 744
23.2502 USD
4 months ago
Sep 10, 2024
Sell 123 K USD
Indig Chaim
Chief Executive Officer
- 5295
23.2502 USD
4 months ago
Sep 10, 2024
Sell 39.9 K USD
Linetsky David
SVP, Life Sciences
- 1716
23.2502 USD
4 months ago
Sep 10, 2024
Sell 2.21 K USD
Linetsky David
SVP, Life Sciences
- 95
23.2502 USD
4 months ago
Sep 10, 2024
Sell 73.2 K USD
Roberts Evan
Chief Operating Officer
- 3148
23.2502 USD
4 months ago
Sep 10, 2024
Sell 17.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 737
23.2502 USD
4 months ago
Sep 10, 2024
Sell 61 K USD
Hoffman Allison C
General Counsel & Secretary
- 2622
23.2502 USD
4 months ago
Sep 11, 2024
Sell 48.4 K USD
Hoffman Allison C
General Counsel & Secretary
- 2072
23.36 USD
4 months ago
Aug 26, 2024
Sell 367 K USD
Hoffman Allison C
General Counsel & Secretary
- 14110
26.027 USD
5 months ago
Jul 29, 2024
Sell 173 USD
Indig Chaim
Chief Executive Officer
- 7
24.75 USD
6 months ago
Jul 18, 2024
Sell 175 K USD
Smith Mark Douglas
Director
- 7000
25 USD
6 months ago
Jul 16, 2024
Sell 43.2 K USD
Linetsky David
SVP, Life Sciences
- 1820
23.7356 USD
6 months ago
Jul 16, 2024
Sell 62.8 K USD
Indig Chaim
Chief Executive Officer
- 2644
23.7356 USD
6 months ago
Jul 16, 2024
Sell 6.72 K USD
Hui Yvonne
Principal Accounting Officer
- 283
23.7356 USD
6 months ago
Jul 16, 2024
Sell 19 K USD
Hoffman Allison C
General Counsel & Secretary
- 800
23.7356 USD
6 months ago
Jul 16, 2024
Sell 18.6 K USD
Gandhi Balaji
Chief Financial Officer
- 783
23.7356 USD
6 months ago
Jul 16, 2024
Sell 8.88 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 374
23.7356 USD
6 months ago
Jul 16, 2024
Sell 39.6 K USD
Roberts Evan
Chief Operating Officer
- 1669
23.7356 USD
6 months ago
Jun 21, 2024
Sell 2.31 K USD
Gunzburg Janet
Principal Accounting Officer
- 114
20.2365 USD
6 months ago
Jun 21, 2024
Sell 546 USD
Linetsky David
SVP, Life Sciences
- 27
20.2365 USD
7 months ago
Jun 18, 2024
Sell 787 USD
Linetsky David
SVP, Life Sciences
- 41
19.1971 USD
7 months ago
Jun 20, 2024
Sell 1.3 K USD
Linetsky David
SVP, Life Sciences
- 66
19.7322 USD
8 months ago
May 01, 2024
Sell 6.01 K USD
Gunzburg Janet
Principal Accounting Officer
- 286
20.9987 USD
9 months ago
Apr 18, 2024
Sell 20.8 K USD
Gunzburg Janet
Principal Accounting Officer
- 912
22.847 USD
9 months ago
Apr 18, 2024
Sell 6.15 K USD
Linetsky David
SVP, Life Sciences
- 269
22.847 USD
9 months ago
Apr 15, 2024
Sell 15.7 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 685
22.8574 USD
9 months ago
Apr 15, 2024
Sell 50.6 K USD
Linetsky David
SVP, Life Sciences
- 2212
22.8574 USD
9 months ago
Apr 15, 2024
Sell 46.4 K USD
Roberts Evan
Chief Operating Officer
- 2029
22.8574 USD
9 months ago
Apr 15, 2024
Sell 28.3 K USD
Hoffman Allison C
General Counsel & Secretary
- 1238
22.8574 USD
9 months ago
Apr 15, 2024
Sell 21.7 K USD
Gandhi Balaji
Chief Financial Officer
- 948
22.8574 USD
9 months ago
Apr 15, 2024
Sell 77.5 K USD
Indig Chaim
Chief Executive Officer
- 3392
22.8574 USD
9 months ago
Apr 10, 2024
Sell 63.9 K USD
Gunzburg Janet
Principal Accounting Officer
- 2768
23.0954 USD
9 months ago
Apr 08, 2024
Sell 124 K USD
Hoffman Allison C
General Counsel & Secretary
- 5494
22.6161 USD
9 months ago
Apr 08, 2024
Sell 1.27 K USD
Hoffman Allison C
General Counsel & Secretary
- 55
23.0163 USD
9 months ago
Apr 09, 2024
Sell 108 K USD
Hoffman Allison C
General Counsel & Secretary
- 4626
23.4241 USD
9 months ago
Apr 08, 2024
Sell 174 K USD
Gandhi Balaji
Chief Financial Officer
- 7700
22.6161 USD
9 months ago
Apr 08, 2024
Sell 1.8 K USD
Gandhi Balaji
Chief Financial Officer
- 78
23.0163 USD
9 months ago
Apr 08, 2024
Sell 270 K USD
Indig Chaim
Chief Executive Officer
- 11923
22.6161 USD
9 months ago
Apr 08, 2024
Sell 2.76 K USD
Indig Chaim
Chief Executive Officer
- 120
23.0163 USD
9 months ago
Apr 08, 2024
Sell 75.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 3320
22.6161 USD
9 months ago
Apr 08, 2024
Sell 783 USD
VanDuyn Amy Beth
SVP, Human Resources
- 34
23.0163 USD
9 months ago
Apr 09, 2024
Sell 88.3 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 3768
23.428 USD
9 months ago
Apr 08, 2024
Sell 161 K USD
Roberts Evan
Chief Operating Officer
- 7106
22.6161 USD
9 months ago
Apr 08, 2024
Sell 1.66 K USD
Roberts Evan
Chief Operating Officer
- 72
23.0163 USD
9 months ago
Apr 08, 2024
Sell 87.6 K USD
Linetsky David
SVP, Life Sciences
- 3875
22.6161 USD
9 months ago
Apr 08, 2024
Sell 898 USD
Linetsky David
SVP, Life Sciences
- 39
23.0163 USD
9 months ago
Apr 08, 2024
Sell 5.54 K USD
Linetsky David
SVP, Life Sciences
- 245
22.6161 USD
9 months ago
Apr 08, 2024
Sell 46 USD
Linetsky David
SVP, Life Sciences
- 2
23.0163 USD
10 months ago
Mar 19, 2024
Sell 65.6 K USD
Gunzburg Janet
Principal Accounting Officer
- 2817
23.2733 USD
9 months ago
Apr 08, 2024
Sell 38.3 K USD
Gunzburg Janet
Principal Accounting Officer
- 1692
22.6161 USD
9 months ago
Apr 08, 2024
Sell 391 USD
Gunzburg Janet
Principal Accounting Officer
- 17
23.0163 USD
9 months ago
Mar 25, 2024
Sell 81.3 K USD
Gandhi Balaji
Chief Financial Officer
- 3504
23.2112 USD
9 months ago
Mar 21, 2024
Sell 586 K USD
Roberts Evan
Chief Operating Officer
- 24962
23.4848 USD
9 months ago
Mar 21, 2024
Sell 24.5 K USD
Roberts Evan
Chief Operating Officer
- 1000
24.4568 USD
10 months ago
Mar 20, 2024
Sell 3.24 K USD
Gunzburg Janet
Principal Accounting Officer
- 137
23.6597 USD
10 months ago
Mar 20, 2024
Sell 710 USD
Linetsky David
SVP, Life Sciences
- 30
23.6597 USD
10 months ago
Mar 18, 2024
Sell 1.02 K USD
Linetsky David
SVP, Life Sciences
- 46
22.2162 USD
10 months ago
Mar 19, 2024
Sell 9.36 K USD
Linetsky David
SVP, Life Sciences
- 402
23.2733 USD
11 months ago
Feb 09, 2024
Sell 13.4 K USD
Gunzburg Janet
Principal Accounting Officer
- 480
28 USD
11 months ago
Feb 02, 2024
Sell 13 K USD
Gunzburg Janet
Principal Accounting Officer
- 480
27 USD
1 year ago
Jan 12, 2024
Sell 4.94 K USD
Gunzburg Janet
Principal Accounting Officer
- 205
24.11 USD
11 months ago
Feb 01, 2024
Sell 8.52 K USD
Gunzburg Janet
Principal Accounting Officer
- 328
25.9898 USD
1 year ago
Jan 16, 2024
Sell 22.9 K USD
Gandhi Balaji
Chief Financial Officer
- 932
24.5455 USD
1 year ago
Jan 17, 2024
Sell 222 K USD
Gandhi Balaji
Chief Financial Officer
- 9192
24.1216 USD
1 year ago
Jan 16, 2024
Sell 18.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 738
24.5455 USD
1 year ago
Jan 17, 2024
Sell 246 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 10213
24.1216 USD
1 year ago
Jan 16, 2024
Sell 32.2 K USD
Davidoff Michael J.
SVP, Payer Business
- 1310
24.5455 USD
1 year ago
Jan 17, 2024
Sell 426 K USD
Davidoff Michael J.
SVP, Payer Business
- 17677
24.1216 USD
1 year ago
Jan 16, 2024
Sell 56.9 K USD
Linetsky David
SVP, Life Sciences
- 2318
24.5455 USD
1 year ago
Jan 17, 2024
Sell 740 K USD
Linetsky David
SVP, Life Sciences
- 30659
24.1216 USD
1 year ago
Jan 16, 2024
Sell 32.3 K USD
Hoffman Allison C
General Counsel & Secretary
- 1316
24.5455 USD
1 year ago
Jan 17, 2024
Sell 183 K USD
Hoffman Allison C
General Counsel & Secretary
- 7605
24.1216 USD
1 year ago
Jan 16, 2024
Sell 55.2 K USD
Roberts Evan
Chief Operating Officer
- 2247
24.5455 USD
1 year ago
Jan 17, 2024
Sell 991 K USD
Roberts Evan
Chief Operating Officer
- 41081
24.1216 USD
1 year ago
Jan 16, 2024
Sell 88 K USD
Indig Chaim
Chief Executive Officer
- 3586
24.5455 USD
1 year ago
Jan 17, 2024
Sell 1.54 M USD
Indig Chaim
Chief Executive Officer
- 63931
24.1216 USD
1 year ago
Dec 19, 2023
Sell 2.8 K USD
Gunzburg Janet
Principal Accounting Officer
- 118
23.723 USD
1 year ago
Dec 18, 2023
Sell 5.42 K USD
Linetsky David
SVP, Life Sciences
- 234
23.1527 USD
1 year ago
Dec 19, 2023
Sell 593 USD
Linetsky David
SVP, Life Sciences
- 25
23.723 USD
1 year ago
Nov 01, 2023
Sell 3.99 K USD
Gunzburg Janet
Principal Accounting Officer
- 298
13.3831 USD
1 year ago
Oct 16, 2023
Sell 19.9 K USD
Davidoff Michael J.
SVP, Payer Business
- 1198
16.609 USD
1 year ago
Oct 16, 2023
Sell 14.3 K USD
Gandhi Balaji
Chief Financial Officer
- 861
16.609 USD
1 year ago
Oct 16, 2023
Sell 11 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 665
16.609 USD
1 year ago
Oct 16, 2023
Sell 21.5 K USD
Hoffman Allison C
General Counsel & Secretary
- 1297
16.609 USD
1 year ago
Oct 16, 2023
Sell 32.7 K USD
Roberts Evan
Chief Operating Officer
- 1971
16.609 USD
1 year ago
Oct 16, 2023
Sell 34.5 K USD
Linetsky David
SVP, Life Sciences
- 2078
16.609 USD
1 year ago
Oct 16, 2023
Sell 54.7 K USD
Indig Chaim
Chief Executive Officer
- 3295
16.609 USD
1 year ago
Sep 18, 2023
Sell 2.47 K USD
Gunzburg Janet
Principal Accounting Officer
- 125
19.7892 USD
1 year ago
Sep 18, 2023
Sell 1.29 K USD
Linetsky David
SVP, Life Sciences
- 66
19.5912 USD
1 year ago
Sep 18, 2023
Sell 749 USD
Linetsky David
SVP, Life Sciences
- 38
19.71 USD
1 year ago
Sep 18, 2023
Sell 515 USD
Linetsky David
SVP, Life Sciences
- 26
19.7892 USD
1 year ago
Sep 13, 2023
Sell 76.2 K USD
Roberts Evan
Chief Operating Officer
- 3751
20.3031 USD
1 year ago
Sep 13, 2023
Sell 3.31 K USD
Roberts Evan
Chief Operating Officer
- 156
21.2047 USD
1 year ago
Sep 13, 2023
Sell 63.5 K USD
Hoffman Allison C
General Counsel & Secretary
- 3126
20.3031 USD
1 year ago
Sep 13, 2023
Sell 2.76 K USD
Hoffman Allison C
General Counsel & Secretary
- 130
21.2047 USD
1 year ago
Sep 14, 2023
Sell 44.6 K USD
Hoffman Allison C
General Counsel & Secretary
- 2210
20.1656 USD
1 year ago
Sep 13, 2023
Sell 35.6 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 1753
20.3031 USD
1 year ago
Sep 13, 2023
Sell 1.55 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 73
21.2047 USD
1 year ago
Sep 14, 2023
Sell 40.3 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 2000
20.1579 USD
1 year ago
Sep 13, 2023
Sell 18.2 K USD
Gunzburg Janet
Principal Accounting Officer
- 897
20.3031 USD
1 year ago
Sep 13, 2023
Sell 785 USD
Gunzburg Janet
Principal Accounting Officer
- 37
21.2047 USD
1 year ago
Sep 13, 2023
Sell 77.1 K USD
Gandhi Balaji
Chief Financial Officer
- 3799
20.3031 USD
1 year ago
Sep 13, 2023
Sell 3.35 K USD
Gandhi Balaji
Chief Financial Officer
- 158
21.2047 USD
1 year ago
Sep 13, 2023
Sell 70.3 K USD
Davidoff Michael J.
SVP, Payer Business
- 3462
20.3031 USD
1 year ago
Sep 13, 2023
Sell 3.05 K USD
Davidoff Michael J.
SVP, Payer Business
- 144
21.2047 USD
1 year ago
Sep 14, 2023
Sell 59.5 K USD
Davidoff Michael J.
SVP, Payer Business
- 2953
20.1616 USD
1 year ago
Sep 13, 2023
Sell 128 K USD
Indig Chaim
Chief Executive Officer
- 6293
20.3031 USD
1 year ago
Sep 13, 2023
Sell 5.56 K USD
Indig Chaim
Chief Executive Officer
- 262
21.2047 USD
1 year ago
Sep 13, 2023
Sell 40.1 K USD
Linetsky David
SVP, Life Sciences
- 1977
20.3031 USD
1 year ago
Sep 13, 2023
Sell 1.74 K USD
Linetsky David
SVP, Life Sciences
- 82
21.2047 USD
1 year ago
Sep 13, 2023
Sell 2.31 K USD
Linetsky David
SVP, Life Sciences
- 114
20.3031 USD
1 year ago
Sep 13, 2023
Sell 106 USD
Linetsky David
SVP, Life Sciences
- 5
21.2047 USD
1 year ago
Jul 21, 2023
Sell 34.1 K USD
Davidoff Michael J.
SVP, Payer Business
- 1075
31.75 USD
1 year ago
May 10, 2023
Sell 107 K USD
Munson Gillian
Director
- 3555
30.0601 USD
1 year ago
Apr 21, 2023
Sell 35.6 K USD
Davidoff Michael J.
SVP, Payer Business
- 1075
33.13 USD
1 year ago
Apr 18, 2023
Sell 239 K USD
Roberts Evan
Chief Operating Officer
- 7452
32.0943 USD
1 year ago
Apr 17, 2023
Sell 18.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 570
31.8401 USD
1 year ago
Apr 17, 2023
Sell 67.2 K USD
Gandhi Balaji
Chief Financial Officer
- 2113
31.8258 USD
1 year ago
Apr 17, 2023
Sell 83.2 K USD
Roberts Evan
Chief Operating Officer
- 2600
32.0111 USD
1 year ago
Apr 14, 2023
Sell 103 K USD
Hoffman Allison C
General Counsel & Secretary
- 3306
31.1607 USD
1 year ago
Apr 12, 2023
Sell 6.4 K USD
Roberts Evan
Chief Operating Officer
- 200
32.01 USD
1 year ago
Apr 11, 2023
Sell 107 K USD
Davidoff Michael J.
SVP, Payer Business
- 3466
30.907 USD
1 year ago
Apr 03, 2023
Sell 82.2 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 2678
30.6903 USD
1 year ago
Apr 03, 2023
Sell 9.51 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 300
31.6933 USD
1 year ago
Apr 03, 2023
Sell 199 K USD
Smith Mark Douglas
Director
- 6500
30.6895 USD
1 year ago
Apr 03, 2023
Sell 15.9 K USD
Smith Mark Douglas
Director
- 500
31.771 USD
1 year ago
Feb 02, 2023
Sell 191 K USD
Rasmussen Randy
Chief Financial Officer
- 4765
40 USD
1 year ago
Feb 02, 2023
Sell 450 K USD
Linetsky David
SVP, Life Sciences
- 11378
39.549 USD
1 year ago
Feb 02, 2023
Sell 12 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 300
40 USD
1 year ago
Feb 02, 2023
Sell 234 K USD
Davidoff Michael J.
SVP, Payer Business
- 5983
39.1189 USD
1 year ago
Feb 02, 2023
Sell 60.5 K USD
Davidoff Michael J.
SVP, Payer Business
- 1530
39.5528 USD
1 year ago
Jan 30, 2023
Sell 441 K USD
Davidoff Michael J.
SVP, Payer Business
- 12293
35.8858 USD
1 year ago
Jan 30, 2023
Sell 590 K USD
Davidoff Michael J.
SVP, Payer Business
- 16262
36.2591 USD
1 year ago
Jan 31, 2023
Sell 124 K USD
Davidoff Michael J.
SVP, Payer Business
- 3265
38.0037 USD
2 years ago
Jan 18, 2023
Sell 23.4 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 649
36.0662 USD
2 years ago
Jan 03, 2023
Sell 265 K USD
Roberts Evan
director: Chief Operating Officer
- 8504
31.1209 USD
2 years ago
Jan 03, 2023
Sell 29.1 K USD
Roberts Evan
director: Chief Operating Officer
- 899
32.3687 USD
2 years ago
Jan 03, 2023
Sell 19.8 K USD
Roberts Evan
director: Chief Operating Officer
- 597
33.1671 USD
2 years ago
Dec 20, 2022
Sell 12.7 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 378
33.7292 USD
2 years ago
Dec 13, 2022
Sell 107 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 3109
34.4 USD
2 years ago
Dec 14, 2022
Sell 28.8 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 801
36 USD
2 years ago
Dec 13, 2022
Sell 394 K USD
Linetsky David
director: SVP, Life Sciences
- 11377
34.6097 USD
2 years ago
Dec 09, 2022
Sell 799 K USD
Linetsky David
director: SVP, Life Sciences
- 26837
29.775 USD
2 years ago
Dec 09, 2022
Sell 247 K USD
Rasmussen Randy
director: Chief Financial Officer
- 8183
30.1686 USD
2 years ago
Dec 09, 2022
Sell 55 K USD
Rasmussen Randy
director: Chief Financial Officer
- 1751
31.4003 USD
2 years ago
Dec 12, 2022
Sell 235 K USD
Rasmussen Randy
director: Chief Financial Officer
- 7395
31.7665 USD
2 years ago
Nov 02, 2022
Sell 238 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 8986
26.4366 USD
2 years ago
Nov 02, 2022
Sell 270 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 9955
27.1435 USD
2 years ago
Nov 02, 2022
Sell 11.2 K USD
VanDuyn Amy Beth
director: SVP, Human Resources
- 400
27.9625 USD
2 years ago
Oct 18, 2022
Sell 27.2 K USD
Davidoff Michael J.
director: SVP, Payer Business
- 1075
25.26 USD
2 years ago
Sep 16, 2022
Sell 35.8 K USD
Davidoff Michael J.
SVP, Payer Business
- 1296
27.6024 USD
2 years ago
Sep 15, 2022
Sell 36.9 K USD
Hoffman Allison C
General Counsel & Secretary
- 1290
28.5782 USD
2 years ago
Jul 21, 2022
Sell 35.1 K USD
Davidoff Michael J.
director: SVP, Payer Business
- 1404
25 USD
2 years ago
Jul 11, 2022
Sell 30.8 K USD
Munson Gillian
director:
- 1221
25.2119 USD
2 years ago
Jun 24, 2022
Sell 127 K USD
Davidoff Michael J.
director: SVP, Payer Business
- 5046
25.1099 USD
2 years ago
May 16, 2022
Sell 33.8 K USD
Munson Gillian
director:
- 2106
16.0566 USD
2 years ago
May 09, 2022
Sell 5.59 K USD
Hoffman Allison C
director: General Counsel & Secretary
- 300
18.6233 USD
3 years ago
Jan 19, 2022
Sell 31.9 K USD
Rasmussen Randy
Chief Financial Officer
- 990
32.2064 USD
3 years ago
Jan 19, 2022
Sell 40.9 K USD
Rasmussen Randy
Chief Financial Officer
- 1238
33.0228 USD
3 years ago
Nov 09, 2021
Sell 532 K USD
Rasmussen Randy
Chief Financial Officer
- 7185
73.9793 USD
3 years ago
Nov 05, 2021
Sell 261 K USD
Linetsky David
SVP, Life Sciences
- 3478
75.1531 USD
3 years ago
Nov 08, 2021
Sell 113 K USD
Linetsky David
SVP, Life Sciences
- 1499
75.1214 USD
3 years ago
Nov 01, 2021
Sell 167 K USD
Linetsky David
SVP, Life Sciences
- 2374
70.419 USD
3 years ago
Nov 01, 2021
Sell 219 K USD
Linetsky David
SVP, Life Sciences
- 3077
71.234 USD
4 years ago
Oct 21, 2020
Sell 379 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 10834
35 USD
3 years ago
Oct 15, 2021
Sell 356 K USD
Linetsky David
SVP, Life Sciences
- 5452
65.3584 USD
3 years ago
Sep 01, 2021
Sell 100 K USD
Linetsky David
SVP, Life Sciences
- 1441
69.6303 USD
3 years ago
Sep 01, 2021
Sell 226 K USD
Linetsky David
SVP, Life Sciences
- 3204
70.6692 USD
3 years ago
Aug 31, 2021
Sell 34.1 K USD
Linetsky David
SVP, Life Sciences
- 474
71.84 USD
3 years ago
Sep 01, 2021
Sell 23.8 K USD
Linetsky David
SVP, Life Sciences
- 333
71.3921 USD
3 years ago
Aug 27, 2021
Sell 277 K USD
Linetsky David
SVP, Life Sciences
- 3932
70.4645 USD
3 years ago
Aug 27, 2021
Sell 383 K USD
Linetsky David
SVP, Life Sciences
- 5336
71.6978 USD
3 years ago
Aug 27, 2021
Sell 867 K USD
Linetsky David
SVP, Life Sciences
- 11987
72.357 USD
3 years ago
Aug 27, 2021
Sell 14.6 K USD
Linetsky David
SVP, Life Sciences
- 200
73.05 USD
3 years ago
Aug 27, 2021
Sell 275 K USD
Indig Chaim
Chief Executive Officer
- 3900
70.4539 USD
3 years ago
Aug 27, 2021
Sell 383 K USD
Indig Chaim
Chief Executive Officer
- 5344
71.6921 USD
3 years ago
Aug 30, 2021
Sell 1.88 M USD
Indig Chaim
Chief Executive Officer
- 26373
71.1166 USD
3 years ago
Aug 27, 2021
Sell 3.05 M USD
Indig Chaim
Chief Executive Officer
- 42142
72.4166 USD
3 years ago
Aug 30, 2021
Sell 2.01 M USD
Indig Chaim
Chief Executive Officer
- 28099
71.5621 USD
3 years ago
Aug 30, 2021
Sell 14.5 K USD
Indig Chaim
Chief Executive Officer
- 200
72.44 USD
3 years ago
Aug 27, 2021
Sell 451 K USD
Indig Chaim
Chief Executive Officer
- 6170
73.124 USD
3 years ago
Aug 25, 2021
Sell 35 K USD
Linetsky David
SVP, Life Sciences
- 500
70.038 USD
3 years ago
Aug 26, 2021
Sell 56.1 K USD
Linetsky David
SVP, Life Sciences
- 800
70.0675 USD
3 years ago
Aug 25, 2021
Sell 42 K USD
Indig Chaim
Chief Executive Officer
- 600
70.03 USD
3 years ago
Aug 26, 2021
Sell 56 K USD
Indig Chaim
Chief Executive Officer
- 800
70.045 USD
3 years ago
Aug 25, 2021
Sell 144 K USD
Hoffman Allison C
General Counsel & Secretary
- 2082
69.05 USD
3 years ago
Aug 05, 2021
Sell 578 K USD
Weintraub Michael
Director
- 8236
70.1253 USD
3 years ago
Aug 05, 2021
Sell 133 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 1936
68.7368 USD
3 years ago
Aug 05, 2021
Sell 162 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 2325
69.8323 USD
3 years ago
Aug 05, 2021
Sell 71.4 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 1012
70.595 USD
3 years ago
Aug 05, 2021
Sell 1.98 M USD
Indig Chaim
Chief Executive Officer
- 28120
70.2705 USD
3 years ago
Aug 06, 2021
Sell 117 K USD
Indig Chaim
Chief Executive Officer
- 1660
70.5326 USD
3 years ago
Jul 29, 2021
Sell 475 K USD
Indig Chaim
Chief Executive Officer
- 6779
70.0294 USD
3 years ago
Jul 30, 2021
Sell 7.14 K USD
Indig Chaim
Chief Executive Officer
- 102
70.001 USD
3 years ago
Jul 29, 2021
Sell 123 K USD
Weintraub Michael
Director
- 1754
70.0234 USD
3 years ago
Jul 30, 2021
Sell 700 USD
Weintraub Michael
Director
- 10
70 USD
3 years ago
Jul 20, 2021
Sell 488 K USD
Weintraub Michael
Director
- 7500
65.0849 USD
3 years ago
Jul 21, 2021
Sell 163 K USD
Weintraub Michael
Director
- 2500
65.1468 USD
3 years ago
Jul 16, 2021
Sell 846 K USD
Weintraub Michael
Director
- 13325
63.5101 USD
3 years ago
Jul 16, 2021
Sell 429 K USD
Weintraub Michael
Director
- 6675
64.2592 USD
3 years ago
Jul 08, 2021
Sell 142 K USD
Munson Gillian
Director
- 2255
62.8975 USD
3 years ago
Jul 08, 2021
Sell 51.2 K USD
Munson Gillian
Director
- 800
64.0125 USD
3 years ago
Jun 28, 2021
Sell 1.94 M USD
Roberts Evan
Chief Operating Officer
- 32075
60.3821 USD
3 years ago
Jun 24, 2021
Sell 1.27 M USD
Roberts Evan
Chief Operating Officer
- 21091
60.0493 USD
3 years ago
Jun 25, 2021
Sell 110 K USD
Roberts Evan
Chief Operating Officer
- 1834
60.0928 USD
3 years ago
Jun 24, 2021
Sell 300 K USD
CAHILL EDWARD L
Director
- 5000
60.0298 USD
3 years ago
Jun 15, 2021
Sell 922 K USD
Roberts Evan
Chief Operating Officer
- 16486
55.9122 USD
3 years ago
Jun 15, 2021
Sell 199 K USD
Roberts Evan
Chief Operating Officer
- 3514
56.6523 USD
3 years ago
Jun 14, 2021
Sell 743 K USD
CAHILL EDWARD L
Director
- 12946
57.4001 USD
3 years ago
Jun 14, 2021
Sell 119 K USD
CAHILL EDWARD L
Director
- 2054
57.9046 USD
3 years ago
May 12, 2021
Sell 74.4 K USD
Munson Gillian
Director
- 1677
44.3901 USD
3 years ago
May 12, 2021
Sell 4.51 K USD
Munson Gillian
Director
- 100
45.11 USD
3 years ago
Apr 09, 2021
Sell 97.5 K USD
Davidoff Michael J.
See Remarks
- 1934
50.4039 USD
3 years ago
Apr 09, 2021
Sell 10.3 K USD
Davidoff Michael J.
See Remarks
- 200
51.515 USD
3 years ago
Apr 01, 2021
Sell 484 K USD
CAHILL EDWARD L
Director
- 8848
54.746 USD
3 years ago
Apr 01, 2021
Sell 340 K USD
CAHILL EDWARD L
Director
- 6152
55.2215 USD
3 years ago
Mar 15, 2021
Sell 2.55 M USD
Linetsky David
SVP, Life Sciences
- 41776
61.0587 USD
3 years ago
Mar 15, 2021
Sell 414 K USD
Linetsky David
SVP, Life Sciences
- 6706
61.6942 USD
3 years ago
Mar 16, 2021
Sell 45.5 K USD
Linetsky David
SVP, Life Sciences
- 778
58.5077 USD
3 years ago
Mar 16, 2021
Sell 30.3 K USD
Linetsky David
SVP, Life Sciences
- 500
60.624 USD
3 years ago
Mar 16, 2021
Sell 18.4 K USD
Linetsky David
SVP, Life Sciences
- 300
61.31 USD
3 years ago
Feb 18, 2021
Sell 582 K USD
CAHILL EDWARD L
Director
- 8118
71.7489 USD
3 years ago
Feb 18, 2021
Sell 64 K USD
CAHILL EDWARD L
Director
- 882
72.577 USD
3 years ago
Feb 18, 2021
Sell 73.6 K USD
CAHILL EDWARD L
Director
- 1000
73.5559 USD
3 years ago
Feb 18, 2021
Sell 4.36 M USD
Altier Thomas
Chief Financial Officer
- 60745
71.7742 USD
3 years ago
Feb 18, 2021
Sell 826 K USD
Altier Thomas
Chief Financial Officer
- 11413
72.3744 USD
3 years ago
Feb 18, 2021
Sell 302 K USD
Altier Thomas
Chief Financial Officer
- 4114
73.509 USD
3 years ago
Feb 19, 2021
Sell 50.9 K USD
Altier Thomas
Chief Financial Officer
- 700
72.6601 USD
3 years ago
Feb 19, 2021
Sell 15 K USD
Altier Thomas
Chief Financial Officer
- 204
73.3922 USD
3 years ago
Jan 29, 2021
Sell 205 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 3150
65.0929 USD
3 years ago
Jan 29, 2021
Sell 941 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 14304
65.8062 USD
3 years ago
Jan 29, 2021
Sell 269 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 4021
66.7875 USD
3 years ago
Jan 29, 2021
Sell 23.9 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 354
67.4446 USD
3 years ago
Jan 22, 2021
Sell 53.8 K USD
Altier Thomas
Chief Financial Officer
- 776
69.3715 USD
3 years ago
Jan 22, 2021
Sell 50.4 K USD
Altier Thomas
Chief Financial Officer
- 719
70.0303 USD
4 years ago
Jan 20, 2021
Sell 64.9 K USD
Indig Chaim
Chief Executive Officer
- 1000
64.8815 USD
4 years ago
Jan 20, 2021
Sell 849 K USD
Indig Chaim
Chief Executive Officer
- 12840
66.1126 USD
4 years ago
Jan 20, 2021
Sell 70 K USD
Indig Chaim
Chief Executive Officer
- 1052
66.4949 USD
4 years ago
Jan 20, 2021
Sell 35.3 K USD
Linetsky David
SVP, Life Sciences
- 544
64.8586 USD
4 years ago
Jan 20, 2021
Sell 416 K USD
Linetsky David
SVP, Life Sciences
- 6282
66.1437 USD
4 years ago
Jan 19, 2021
Sell 301 K USD
Altier Thomas
Chief Financial Officer
- 4704
64.0043 USD
4 years ago
Jan 19, 2021
Sell 1.13 M USD
Weintraub Michael
Director
- 17782
63.6698 USD
4 years ago
Jan 19, 2021
Sell 1.1 M USD
Weintraub Michael
Director
- 17218
64.0572 USD
4 years ago
Jan 19, 2021
Sell 330 K USD
Linetsky David
SVP, Life Sciences
- 5136
64.2756 USD
4 years ago
Jan 19, 2021
Sell 683 K USD
Indig Chaim
Chief Executive Officer
- 10772
63.4081 USD
4 years ago
Jan 15, 2021
Sell 382 K USD
Indig Chaim
Chief Executive Officer
- 6214
61.4023 USD
4 years ago
Jan 15, 2021
Sell 2.75 M USD
Indig Chaim
Chief Executive Officer
- 43905
62.6958 USD
4 years ago
Jan 19, 2021
Sell 3.15 M USD
Indig Chaim
Chief Executive Officer
- 49214
64.0685 USD
4 years ago
Jan 15, 2021
Sell 1.58 M USD
Indig Chaim
Chief Executive Officer
- 25003
63.3556 USD
4 years ago
Jan 19, 2021
Sell 332 K USD
Roberts Evan
Chief Operating Officer
- 5200
63.8476 USD
4 years ago
Jan 19, 2021
Sell 19.3 K USD
Roberts Evan
Chief Operating Officer
- 300
64.3033 USD
4 years ago
Jan 04, 2021
Sell 1.54 M USD
Roberts Evan
Chief Operating Officer
- 29728
51.8353 USD
4 years ago
Jan 04, 2021
Sell 2.24 M USD
Roberts Evan
Chief Operating Officer
- 42382
52.743 USD
4 years ago
Jan 04, 2021
Sell 376 K USD
Roberts Evan
Chief Operating Officer
- 7035
53.3934 USD
4 years ago
Jan 04, 2021
Sell 59.7 K USD
Roberts Evan
Chief Operating Officer
- 1100
54.2536 USD
4 years ago
Jan 05, 2021
Sell 867 K USD
Roberts Evan
Chief Operating Officer
- 16275
53.2647 USD
4 years ago
Jan 05, 2021
Sell 280 K USD
Roberts Evan
Chief Operating Officer
- 5193
53.935 USD
4 years ago
Jan 04, 2021
Sell 152 K USD
Smith Mark Douglas
Director
- 2911
52.0669 USD
4 years ago
Jan 04, 2021
Sell 148 K USD
Smith Mark Douglas
Director
- 2789
52.9312 USD
4 years ago
Jan 04, 2021
Sell 16.2 K USD
Smith Mark Douglas
Director
- 300
54.0633 USD
4 years ago
Jan 04, 2021
Sell 27.1 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 500
54.256 USD
4 years ago
Dec 24, 2020
Sell 1.39 M USD
CAHILL EDWARD L
Director
- 24370
57.2212 USD
4 years ago
Dec 16, 2020
Sell 1.27 M USD
Pegus Cheryl
Director
- 22732
55.8283 USD
4 years ago
Dec 17, 2020
Sell 472 K USD
Pegus Cheryl
Director
- 8415
56.1488 USD
4 years ago
Oct 22, 2020
Sell 3.25 M USD
Altier Thomas
Chief Financial Officer
- 86237
37.6468 USD
4 years ago
Oct 23, 2020
Sell 331 K USD
Altier Thomas
Chief Financial Officer
- 8669
38.2059 USD
4 years ago
Oct 12, 2020
Sell 218 K USD
Altier Thomas
Chief Financial Officer
- 6779
32.1255 USD
4 years ago
Oct 01, 2020
Sell 131 K USD
Linetsky David
SVP, Life Sciences
- 4222
30.9209 USD
4 years ago
Oct 01, 2020
Sell 8.12 K USD
Linetsky David
SVP, Life Sciences
- 255
31.84 USD
4 years ago
Oct 01, 2020
Sell 457 K USD
Roberts Evan
Chief Operating Officer
- 14774
30.9295 USD
4 years ago
Sep 11, 2020
Sell 189 K USD
Altier Thomas
Chief Financial Officer
- 6745
27.9822 USD
4 years ago
Sep 11, 2020
Sell 972 USD
Altier Thomas
Chief Financial Officer
- 34
28.6 USD
4 years ago
Aug 17, 2020
Sell 74.6 K USD
Kallenbach Charles
General Counsel & Secretary
- 2500
29.8372 USD
4 years ago
Aug 10, 2020
Sell 182 K USD
Smith Mark Douglas
Director
- 6000
30.3041 USD
4 years ago
Aug 11, 2020
Sell 189 K USD
Altier Thomas
Chief Financial Officer
- 6279
30.0459 USD
4 years ago
Aug 11, 2020
Sell 15.4 K USD
Altier Thomas
Chief Financial Officer
- 500
30.754 USD
4 years ago
Jul 31, 2020
Sell 264 K USD
Nathan Daniel
Chief Technology Officer
- 8804
30.0308 USD
4 years ago
Jul 21, 2020
Sell 264 K USD
CAHILL EDWARD L
Director
- 9080
29.022 USD
4 years ago
Jul 17, 2020
Sell 73.2 K USD
Kallenbach Charles
General Counsel & Secretary
- 2500
29.2934 USD
4 years ago
Jul 17, 2020
Sell 1.13 M USD
Nathan Daniel
Chief Technology Officer
- 38683
29.2488 USD
4 years ago
Jul 01, 2020
Sell 356 K USD
Roberts Evan
Chief Operating Officer
- 12500
28.4498 USD
4 years ago
Jul 01, 2020
Sell 126 K USD
Linetsky David
SVP, Life Sciences
- 4475
28.2449 USD
4 years ago
Jun 17, 2020
Sell 73.1 K USD
Kallenbach Charles
General Counsel & Secretary
- 2500
29.2581 USD
4 years ago
Jun 12, 2020
Sell 142 K USD
Munson Gillian
Director
- 5000
28.32 USD
4 years ago
Apr 09, 2020
Sell 86.1 K USD
Davidoff Michael J.
See Remarks
- 4284
20.103 USD
4 years ago
Apr 01, 2020
Sell 28.3 K USD
Davidoff Michael J.
See Remarks
- 1404
20.1314 USD
4 years ago
May 18, 2020
Sell 68 K USD
Kallenbach Charles
General Counsel & Secretary
- 2500
27.2 USD
4 years ago
May 07, 2020
Sell 6.63 K USD
Linetsky David
SVP, Life Sciences
- 255
26 USD
4 years ago
May 01, 2020
Sell 26.7 K USD
Altier Thomas
Chief Financial Officer
- 1096
24.3374 USD
4 years ago
May 01, 2020
Sell 96.2 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 3900
24.6649 USD
4 years ago
May 01, 2020
Sell 239 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 9574
24.9627 USD
4 years ago
Apr 27, 2020
Sell 110 K USD
Linetsky David
SVP, Life Sciences
- 4220
26 USD
4 years ago
Apr 23, 2020
Sell 125 K USD
Kallenbach Charles
General Counsel & Secretary
- 5000
25 USD
4 years ago
Apr 09, 2020
Sell 86.1 K USD
Davidoff Michael J.
See Remarks
- 4285
20.103 USD
4 years ago
Apr 01, 2020
Sell 28.3 K USD
Davidoff Michael J.
See Remarks
- 1404
20.1314 USD
4 years ago
Mar 30, 2020
Sell 13.8 K USD
Davidoff Michael J.
See Remarks
- 689
20 USD
4 years ago
Mar 26, 2020
Sell 77.3 K USD
Davidoff Michael J.
See Remarks
- 3851
20.0629 USD
4 years ago
Mar 23, 2020
Sell 14 K USD
Davidoff Michael J.
See Remarks
- 700
20.0636 USD
4 years ago
Mar 02, 2020
Sell 297 K USD
Davidoff Michael J.
See Remarks
- 10115
29.3895 USD
4 years ago
Mar 02, 2020
Sell 197 K USD
Davidoff Michael J.
See Remarks
- 6451
30.476 USD
4 years ago
Mar 02, 2020
Sell 15.5 K USD
Davidoff Michael J.
See Remarks
- 500
30.952 USD
4 years ago
Feb 19, 2020
Sell 1.64 K USD
Kallenbach Charles
General Counsel & Secretary
- 50
32.85 USD
4 years ago
Feb 19, 2020
Sell 308 K USD
Nathan Daniel
Chief Technology Officer
- 9142
33.7024 USD
4 years ago
Feb 18, 2020
Sell 297 K USD
Nathan Daniel
Chief Technology Officer
- 9061
32.8218 USD
4 years ago
Feb 18, 2020
Sell 80.4 K USD
Kallenbach Charles
General Counsel & Secretary
- 2450
32.8217 USD
4 years ago
Feb 18, 2020
Sell 93.4 K USD
Linetsky David
SVP, Life Sciences
- 2844
32.8374 USD
4 years ago
Feb 18, 2020
Sell 11.3 K USD
Linetsky David
SVP, Life Sciences
- 344
32.9308 USD
4 years ago
Feb 12, 2020
Sell 347 K USD
Weintraub Michael
Director
- 10680
32.5092 USD
4 years ago
Feb 11, 2020
Sell 302 K USD
Weintraub Michael
Director
- 9143
33.0225 USD
4 years ago
Feb 10, 2020
Sell 498 K USD
Weintraub Michael
Director
- 15177
32.7878 USD
4 years ago
Feb 10, 2020
Sell 224 K USD
VanDuyn Amy Beth
SVP, Human Resources
- 6826
32.8414 USD
4 years ago
Feb 10, 2020
Sell 360 K USD
Altier Thomas
Chief Financial Officer
- 10955
32.8501 USD
4 years ago
Feb 06, 2020
Sell 144 K USD
Davidoff Michael J.
See Remarks
- 4350
33.0536 USD
4 years ago
Feb 06, 2020
Sell 6.8 K USD
Davidoff Michael J.
See Remarks
- 200
34.01 USD
4 years ago
Feb 06, 2020
Sell 144 K USD
Davidoff Michael J.
See Remarks
- 4350
33.0536 USD
4 years ago
Feb 06, 2020
Sell 6.8 K USD
Davidoff Michael J.
See Remarks
- 200
34.01 USD
4 years ago
Feb 06, 2020
Sell 2.65 M USD
Indig Chaim
Chief Executive Officer
- 80000
33.1116 USD
4 years ago
Feb 03, 2020
Sell 1.48 M USD
Indig Chaim
Chief Executive Officer
- 48145
30.7285 USD
4 years ago
Feb 03, 2020
Sell 245 K USD
Indig Chaim
Chief Executive Officer
- 7808
31.3241 USD
4 years ago
Feb 04, 2020
Sell 1.91 M USD
Indig Chaim
Chief Executive Officer
- 60737
31.4418 USD
4 years ago
Feb 03, 2020
Sell 274 K USD
Davidoff Michael J.
See Remarks
- 8911
30.7853 USD
4 years ago
Feb 03, 2020
Sell 77.3 K USD
Davidoff Michael J.
See Remarks
- 2466
31.3363 USD
4 years ago
Jan 27, 2020
Sell 2.03 M USD
Roberts Evan
Chief Operating Officer
- 69448
29.1748 USD
4 years ago
Jan 27, 2020
Sell 2.03 M USD
Roberts Evan
Chief Operating Officer
- 69448
29.1748 USD
5 years ago
Dec 17, 2019
Sell 8.44 M USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 344599
24.479 USD
5 years ago
Dec 17, 2019
Sell 164 K USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 6716
24.479 USD
5 years ago
Dec 17, 2019
Sell 84.4 K USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 3446
24.479 USD
5 years ago
Dec 17, 2019
Sell 57.8 K USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 2360
24.479 USD
5 years ago
Dec 17, 2019
Sell 46.9 M USD
Perricelli Scott
Director
- 1915728
24.479 USD
5 years ago
Dec 17, 2019
Sell 2.06 M USD
Perricelli Scott
Director
- 84272
24.479 USD
5 years ago
Dec 17, 2019
Sell 46.9 M USD
LLR Capital IV, LLC
10 percent owner
- 1915728
24.479 USD
5 years ago
Dec 17, 2019
Sell 2.06 M USD
LLR Capital IV, LLC
10 percent owner
- 84272
24.479 USD
5 years ago
Dec 17, 2019
Sell 12.2 M USD
Pegus Cheryl
Director
- 500000
24.479 USD
5 years ago
Dec 17, 2019
Sell 53.4 M USD
HLM VENTURE PARTNERS II, L.P.
10 percent owner
- 2181577
24.479 USD
5 years ago
Dec 17, 2019
Sell 53.4 M USD
CAHILL EDWARD L
director, 10 percent owner:
- 2181577
24.479 USD
5 years ago
Jul 22, 2019
Sell 9.72 M USD
HLM VENTURE PARTNERS II, L.P.
10 percent owner
- 540229
18 USD
5 years ago
Jul 22, 2019
Sell 6.89 M USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 382887
18 USD
5 years ago
Jul 22, 2019
Sell 134 K USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 7462
18 USD
5 years ago
Jul 22, 2019
Sell 68.9 K USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 3828
18 USD
5 years ago
Jul 22, 2019
Sell 47.2 K USD
Polaris Venture Management Co. V, L.L.C.
10 percent owner
- 2622
18 USD
5 years ago
Jul 22, 2019
Sell 9.72 M USD
CAHILL EDWARD L
director, 10 percent owner:
- 540229
18 USD
5 years ago
Jul 22, 2019
Sell 6.04 M USD
CHV II, L.P.
10 percent owner
- 335767
18 USD
5 years ago
Jul 22, 2019
Sell 5.05 M USD
Pegus Cheryl
Director
- 280689
18 USD
5 years ago
Jul 22, 2019
Sell 12.8 M USD
LLR Capital IV, LLC
10 percent owner
- 712065
18 USD
5 years ago
Jul 22, 2019
Sell 564 K USD
LLR Capital IV, LLC
10 percent owner
- 31323
18 USD
5 years ago
Jul 22, 2019
Sell 12.8 M USD
Perricelli Scott
Director
- 712065
18 USD
5 years ago
Jul 22, 2019
Sell 564 K USD
Perricelli Scott
Director
- 31323
18 USD
7. News
Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High? The consensus price target hints at a 25% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com - 4 weeks ago
Phreesia Has Turned The Corner, Can It Continue To Mend? Phreesia's Q3 earnings show solid revenue growth, but customer growth is decelerating, impacting overall performance. Fiscal 2025 guidance improved with higher EBITDA and tighter revenue estimates, while fiscal 2026 projects slower revenue growth but significant EBITDA improvement. Strong cash flow and disciplined expense management are encouraging, with the company maintaining positive cash flows and holding $82M in cash. seekingalpha.com - 1 month ago
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript seekingalpha.com - 1 month ago
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 1 month ago
Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates Phreesia (PHR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.58 per share a year ago. zacks.com - 1 month ago
Phreesia Announces Third Quarter Fiscal 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia,” said CEO and Co-Founder Chaim Indig. “Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in.” Please visit the Phreesia investor relations website. businesswire.com - 1 month ago
North American Morning Briefing : Global Ad Shares -2- Lundin Mining Announces Sale to Boliden of its Neves-Corvo operation in Portugal and Zinkgruvan operation in Sweden for Up to $1.52 Billion: Lundin To Receive Upfront Cash Consideration of $1.37B Upon Closing; To Also Get up to $150M in Contingent Cash Upon Satisfaction of Condition; Proceeds Will Strengthen Balance Sheet and Support Growth Plans in the Vicuña District Expected Major Events for Monday aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); 00:01/UK: Nov KPMG and REC UK Report on Jobs 04:30/JPN: Nov Corporate Insolvencies 05:00/JPN: Nov Economy Watchers Survey 07:00/GER: 3Q Labour cost index 15:00/US: Oct Monthly Wholesale Trade 15:00/US: Nov Employment Trends Index 23:50/JPN: Nov Money Stock, Broadly-defined Liquidity All times in GMT. Powered by Kantar Media and Dow Jones. Expected Earnings for Monday Amtech Systems Inc (ASYS) is expected to report $-0.01 for 4Q. Anavex Life Sciences Corp (AVXL) is expected to report $-0.16 for 4Q. Avalon Advanced Materials is expected to report for 4Q. Braze Inc (BRZE) is expected to report $-0.30 for 3Q. Buckle Inc (BKE) is expected to report. C3.ai Inc (AI) is expected to report $-0.60 for 2Q. Casey's General Stores Inc (CASY) is expected to report $4.25 for 2Q. Centene Corp (CNC) is expected to report for Full year. Digital Ally Inc (DGLY) is expected to report for 3Q. Franklin Resources Inc (BEN) is expected to report. Genasys Inc (GNSS) is expected to report $-0.11 for 4Q. Healthequity Inc (HQY) is expected to report $0.24 for 3Q. MongoDB Inc (MDB) is expected to report $-0.83 for 3Q. NexPoint Diversified Real Estate Trust (NXDT) is expected to report for 3Q. North West Co Inc (NWC.T) is expected to report $0.77 for 3Q. Oil-Dri Corp of America (ODC) is expected to report for 1Q. Oracle Corp (ORCL) is expected to report $1.06 for 2Q. Phreesia Inc (PHR) is expected to report $-0.27 for 3Q. Planet Labs PBC (PL) is expected to report $-0.08 for 3Q. Remark Holdings Inc (MARK) is expected to report $-0.19 for 3Q. Rent the Runway Inc (RENT) is expected to report for 3Q. Smart Share Global Ltd - ADR (EM) is expected to report for 3Q. Talis Biomedical Corp (TLIS) is expected to report for 3Q. Titan Pharmaceuticals Inc (TTNP) is expected to report for 3Q. Toll Brothers Inc (TOL) is expected to report $4.34 for 4Q. Vail Resorts (MTN) is expected to report $-4.96 for 1Q. VersaBank is expected to report $0.29 for 4Q. Webco Industries Inc (WEBC) is expected to report for 1Q. Yext Inc (YEXT) is expected to report $0.06 for 3Q. Powered by Kantar Media and Dow Jones. ANALYST RATINGS ACTIONS Altria Raised to Buy From Neutral by B of A Securities Argan Cut to Market Perform From Market Outperform by CJS Securities Asana Raised to Sector Weight From Underweight by Keybanc Brixmor Property Group Raised to Outperform From Market Perform by BMO Capital Deere & Co Cut to Hold From Buy by Jefferies DocuSign Cut to Reduce From Hold by HSBC Dollar General Raised to Buy From Underperform by B of A Securities Duckhorn Portfolio Cut to Hold From Buy by Jefferies EPAM Systems Raised to Buy From Neutral by Goldman Sachs Fortrea Holdings Cut to Neutral From Outperform by Baird GrafTech International Raised to Neutral From Underweight by JP Morgan Hewlett Packard Ent Raised to Buy From Neutral by Citigroup Kennametal Cut to Hold From Buy by Jefferies Molson Coors Beverage Raised to Buy From Neutral by B of A Securities ONE Gas Cut to Neutral From Buy by Ladenburg Thalmann Paccar Cut to Hold From Buy by Jefferies Peloton Interactive Raised to Neutral From Sell by UBS PJT Partners Raised to Neutral From Sell by UBS PotlatchDeltic Raised to Outperform From Market Perform by BMO Capital ProFrac Holding Cut to Underweight From Neutral by JP Morgan Prologis Cut to Underperform From Market Perform by BMO Capital ProPetro Holding Raised to Neutral From Underweight by JP Morgan Republic Services Raised to Outperform From Market Perform by BMO Capital Robinhood Markets Raised to Buy From Neutral by Goldman Sachs SiteOne Landscape Supply Raised to Buy From Hold by Jefferies Smith & Wesson Brands Cut to Hold From Buy by Craig-Hallum Smith & Wesson Brands Cut to Hold From Buy by Lake Street Timken Raised to Buy From Hold by Jefferies WesBanco Raised to Strong Buy From Outperform by Raymond James Weyerhaeuser Raised to Outperform From Market Perform by BMO Capital This article is a text version of a Wall Street Journal newsletter published earlier today. (END) Dow Jones Newswires 12-09-24 0634ET https://www.marketscreener.com - 1 month ago
Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics Evaluate the expected performance of Phreesia (PHR) for the quarter ended October 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com - 1 month ago
Phreesia Named to The Software Report's “Top 100 Software Companies” for the Third Consecutive Year ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year. businesswire.com - 1 month ago
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last? Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. zacks.com - 2 months ago
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024. businesswire.com - 2 months ago
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform. businesswire.com - 2 months ago
8. Profile Summary

Phreesia, Inc. PHR

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.58 B
Dividend Yield 0.00%
Description Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Contact 434 Fayetteville Street, Raleigh, NC, 27601 https://www.phreesia.com
IPO Date July 18, 2019
Employees 1438
Officers Mr. Ashwin G. Uttamchandani Vice President of Sales & Marketing Operations Mr. David Linetsky Senior Vice President of Life Sciences Ms. Allison C. Hoffman J.D. General Counsel & Secretary Ms. Amy Beth VanDuyn Senior Vice President of Human Resources Mr. Chaim Indig Co-Founder, Chief Executive Officer & Director Mr. Evan Roberts Co-Founder & Chief Operating Officer Ms. Yvonne Hui Vice President & Principal Accounting Officer Ms. Maureen McKinney Vice President of Corporate Communications Mr. Jack Callahan Chief Technology Officer Mr. Balaji Gandhi Chief Financial Officer